Targets for medical therapy in obesity (Q38020702)

27 August 2017

Targets for medical therapy in obesity (English)

1 reference

27 August 2017

0 references

Maja Baretić

1

1 reference

27 August 2017

20 June 2012

1 reference

27 August 2017

1 reference

27 August 2017

30

1 reference

27 August 2017

2

1 reference

27 August 2017

168-172

1 reference

The European charter for counteracting obesity: a late but important step towards action. Observations on the WHO-Europe ministerial conference, Istanbul, November 15-17, 2006.

27 August 2017

1 reference

Guidance for the clinical evaluation of weight-control drugs

21 January 2018

1 reference

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects

21 January 2018

1 reference

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients

21 January 2018

1 reference

The incretin pathway as a new therapeutic target for obesity

21 January 2018

1 reference

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

21 January 2018

1 reference

A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder

21 January 2018

1 reference

Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000336672

1 reference

27 August 2017

1 reference

PubMed ID

22722433